Rifaximin has a Favorable Long-Term Safety Profile for Maintenance of Remission from Overt Hepatic Encephalopathy

Autor:	Samuel H. Sigal, Arun J. Sanyal, Kunal Merchant, Nathan M. Bass, Fred Poordad, Muhammad Y. Sheikh, Ravikumar Vemuru, Audrey L. Shaw, Enoch Bortey, Todd Frederick, Kevin D. Mullen, Shirley Huang, Bal Raj Bhandari, William P. Forbes
Rok vydání:	2009
Předmět:	medicine.medical_specialty Hepatology business.industry Gastroenterology medicine.disease Rifaximin chemistry.chemical_compound chemistry Internal medicine medicine Long term safety business Hepatic encephalopathy
Zdroj:	American Journal of Gastroenterology. 104:S136
ISSN:	0002-9270
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ce90ab42758384769531dd2a4809f67f https://doi.org/10.14309/00000434-200910003-00360 Zobrazit plný text záznamu